GDiseases, Disorders & Medical DisciplinesEIN: 030473460· Ruling Year: 2002

Brittany Pasqual Pediatric Oncology Research Foundation

Somerville, New Jersey

CHealth Score
40C

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Below Average

💰
$6K
Total Revenue
📊
$11K
Total Expenses
🏦
$168K
Net Assets
📋
N/A
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-17.8%
Year-over-year change (2022 → 2023)
Net Margin
-85.0%
Revenue minus expenses as % of revenue

Filing History

13 filings on record
YearRevenueExpensesAssets
2023$6,09218%$11,27013%$168,3045%
2022$7,40720%$9,97528%$160,48915%
2021$9,2569%$7,79040%$189,67817%
2020$10,164191%$12,953642%$162,6763%
2019$3,49714%$1,74548%$157,4688%
2018$4,05829%$3,355708%$145,3443%
2017$3,13641%$41582%$150,2637%
2016$2,22813%$2,351167%$140,7331%
2015$2,553134%$88017%$138,8632%
2014$1,09327%$7554%$141,823
2013$85935%$78440%$141,5231%
2012$1,33148%$1,30999%$139,963
2011$902$101,539$139,408

Frequently Asked Questions

What does Brittany Pasqual Pediatric Oncology Research Foundation do?

Brittany Pasqual Pediatric Oncology Research Foundation is a diseases, disorders & medical disciplines nonprofit organization based in New Jersey. It is classified under NTEE code G30 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Brittany Pasqual Pediatric Oncology Research Foundation financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Brittany Pasqual Pediatric Oncology Research Foundation.

How much revenue does Brittany Pasqual Pediatric Oncology Research Foundation generate?

Brittany Pasqual Pediatric Oncology Research Foundation reports $14K in annual revenue and holds $177K in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Diseases, Disorders & Medical Disciplines category, or browse all nonprofits in New Jersey.